Cite Filings / KYMR / 0001950047-24-005451
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
144

Sale of Securities

Kymera Therapeutics, Inc. · Filed 2024-07-16 · Acc 0001950047-24-005451

Documents 1

  • 144 Sale of Securities , xsl144X01/primary_doc.xml

Around this filing

  • 2024-07-23 144 Sale of Securities
  • 2024-07-16 144 Sale of Securities
  • 2024-07-16 4 Chief Medical Officer sold 39,600 shares at an average $45.53 ($1,803,143)
  • 2024-07-15 144 Sale of Securities
  • 2024-07-09 144 Sale of Securities
  • 2024-07-09 144 Sale of Securities
  • 2024-07-09 4 Director sold 453,960 shares at an average $38.21 ($17,346,919)

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading xsl144X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…